Stockscreener 앱 받기
527.05
0.45%
2.34
Thermo Fisher Scientific Inc 주식(TMO)의 최신 뉴스
Thermo Fisher stock holds steady as investors await catalysts - ad-hoc-news.de
Thermo Fisher Looks To Block Former Exec's Move To Fortrea - Law360
Thermo Fisher stock holds steady as investors focus on life-science demand - ad-hoc-news.de
Thermo Fisher Scientific (TMO) Announces Consistent Quarterly Di - GuruFocus
Thermo Fisher declares $0.47 quarterly dividend By Investing.com - Investing.com Nigeria
Thermo Fisher Scientific Keeps Quarterly Dividend at $0.47 per Share, Payable Oct. 15 to Holders of Record Sept. 15 - marketscreener.com
Press Release: Thermo Fisher Scientific Announces Quarterly Dividend - Moomoo
Thermo Fisher Scientific to lay off 69 - In Business Madison
Thermo Fisher Scientific Inc. stock rises Thursday, outperforms market - MarketWatch
Thermo Fisher Q2 Preview: Buy Before The Recovery (NYSE:TMO) - Seeking Alpha
Thermo Fisher Scientific strengthens its life science platform as demand for lab tools stays resilie - AD HOC NEWS
Thermo Fisher Sci. steady after recent updates. Investors focus on healthcare demand - Ad-hoc-news.de
Thermo Fisher Scientific Inc. stock falls Wednesday, underperforms market - MarketWatch
Thermo Fisher expands its scientific footprint as investors assess long-term growth - Ad-hoc-news.de
Thermo Fisher Scientific Launches GENESYS G5 UV-Visible Spectrophotometer Series - Food Safety Magazine
Cell Culture Media Market worth $12.9 billion by 2033: Biologics Manufacturing and Cell Therapy Expansion Accelerate Growth for Avantor, Thermo Fisher Scientific, and Lonza Group AG - PR Newswire
Thermo Fisher's Patheon becomes exclusive third-party CDMO for KinetiSol technology - Manufacturing Chemist
Thermo Fisher (TMO) Wins FBI Approval For Rapid DNA Tool In Crime Investigations - Yahoo Finance
Thermo Fisher Scientific Expands Orbitrap Innovation Across Research, Biopharma and Applied Testing at ASMS 2026 - AOL.com
Thermo Fisher Scientific Launches New Quality Assurance Software - Clinical Lab Products
Thermo Fisher Scientific Receives First FBI Approval for Rapid DNA Crime Scene Profiles Eligible for National CODIS Searches - AOL.com
TMO Maintained by Evercore ISI Group -- Price Target Lowered to $570 - GuruFocus
Thermo Fisher Scientific Inc. stock falls Monday, underperforms market - MarketWatch
Evercore ISI Adjusts Price Target on Thermo Fisher Scientific to $570 From $575 - marketscreener.com
Thermo Fisher Scientific Inc (TMO) Stock Analysis: Evaluating The 13.91% Potential Upside - DirectorsTalk Interviews
Environmental DNA Market Set to Surge to USD 5.61 Billion by 2031 with 10.2% CAGR - GlobeNewswire Inc.
Shapiro Administration Highlights the Need for Funding to Grow Pennsylvania’s Innovation Economy During Visit to Thermo Fisher Scientific in Dauphin County - PA Department of Community & Economic Development (.gov)
Thermo Fisher launches LabLink 360 software to streamline QC review workflows - Select Science
Kavaljer Investmentbolagsfond June 2026 – Thermo Fisher and Siemens New Holdings - marketscreener.com
Arcturus Therapeutics Announces Strategic Collaboration With Thermo Fisher Scientific - TradingView
Thermo Fisher to back Arcturus (NASDAQ: ARCT) ARCT-032 Phase 3 and manufacturing - Stock Titan
Arcturus Therapeutics Announces Strategic Collaboration with Thermo Fisher Scientific to Advance ARCT-032 for Cystic Fibrosis - Business Wire
Thermo Fisher Scientific Inc. stock rises Wednesday, outperforms market - MarketWatch
Thermo Fisher NanoDrop OneC from Thermo Fisher Scientific Inc.compact UV-Vis spectrophotometer po - AD HOC NEWS
Thermo Fisher Scientific to Hold Earnings Conference Call on Thursday, July 23, 2026 - BioSpace
Press Release: Thermo Fisher Scientific to Hold Earnings Conference Call on Thursday, July 23, 2026 - Moomoo
Form 4 Thermo Fisher Scientific For: 30 June By Investing.com - Investing.com Canada
Thermo Fisher (NYSE: TMO) director awarded new phantom stock units as deferred pay - Stock Titan
Thermo Fisher (TMO) director adds phantom stock units via deferred pay grant - Stock Titan
Thermo Fisher (NYSE: TMO) director awarded new phantom stock units - Stock Titan
Thermo Fisher (NYSE: TMO) director defers fees into phantom stock units - Stock Titan
Thermo Fisher (TMO) director receives phantom stock unit award under deferred plan - Stock Titan
Thermo Fisher Scientific’s PPD Clinical Research Business Collabo - The National Law Review
AustinPx Expands KinetiSol™ Technology Commercial Access through Thermo Fisher Scientific Collaboration - 01net
Thermo Fisher Scientific Expands HLA-DQ Testing Coverage for Transplant Antibody Assessment - Clinical Lab Products
Thermo Fisher Scientific Earnings Preview: What to Expect - Yahoo Finance
Thermo Fisher Scientific Agrees to Buy Clario Holdings for $8.88 Billion - MSN
Genedrive Teams Up with Thermo Fisher Scientific to Develop Laboratory-based Genetic Test - marketscreener.com
genedrive shares climb 8% on Thermo Fisher pharmacogenetic testing deal - Proactive Investors
Genedrive Partners with Thermo Fisher to Expand CYP2C19 Diagnostic Portfolio (GDR) - Yahoo Finance UK
Thermo Fisher Scientific: Gradually Getting Cheaper - Seeking Alpha
REGGenedrive PLCCYP2C19 Agreement with Thermo Fisher Scientific - TradingView
Thermo Fisher Scientific Inc.(NYSE: TMO) added to Russell 1000 Dynamic Index - marketscreener.com
Thermo Fisher outlines capital plans for 2030, shares tracked against S&P 500 peers - Ad-hoc-news.de
Bernstein Says Life Science Sector is Improving, Resumes Thermo Fisher Scientific (TMO) Coverage - Insider Monkey
Thermo Fisher Scientific Inc. Shs Cert Deposito Arg Repr 0.0454545 Sh Actuals & Estimates (BCBA:TMOD) - TradingView
The Axion M200 from Thermo Fisher Scientific Inc.compact microscope for crowded benchtops - Ad-hoc-news.de
Thermo Fisher extends its diagnostics reach, shares supported by strong S&P 500 positioning - Ad-hoc-news.de
Thermo Fisher Scientific Inc. Shs Cert Deposito Arg Repr 0.0454545 Sh Actuals & Estimates (BCBA:TMOC) - TradingView
Thermo Fisher Scientific Inc. stock rises Friday, outperforms market - MarketWatch
Bernstein SocGen resumes Thermo Fisher stock coverage with market perform - Investing.com
Thermo Fisher (TMO) Coverage Resumed with Market Perform Rating and $520 Target - GuruFocus
1.57%
4.22%
자본화:
|
볼륨(24시간):